WhatFinger

Chief Scientific Adviser holds a deferred bonus of 43,111 shares worth £600,000

Conflict of interest row as it emerges Chief Scientific Officer Sir Patrick Vallance has £600,000 of shares in vaccine maker

By Daily Mail ——--September 24, 2020

News Headlines | CFP Comments | Reader Friendly | Subscribe | Email Us

Sir Patrick Vallance has a £600,000 shareholding in a pharmaceuticals giant which is racing to develop a Covid vaccine for the Government, a report has revealed. The Chief Scientific Adviser holds the deferred bonus of 43,111 shares in GlaxoSmithKline (GSK) from his time as president of the multinational company.-- More...

Support Canada Free Press

Donate
Subscribe

View Comments
Daily Mail——

The Daily Mail is a British daily middle-market tabloid newspaper owned by the Daily Mail and General Trust and published in London. It is the United Kingdom’s second-biggest-selling daily newspaper after The Sun.

VIEW Comments

Sponsored